A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater ...

RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

"ArkBio commences Phase II study of AK0610 for RSV prevention" was originally created and published by Clinical Trials Arena, ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

Increasing respiratory syncytial virus (RSV) vaccination among older adults could prevent up to 1600 deaths and 20,000 ...

ED visits RSV tick know as cases rise among children under 4, signaling the start of respiratory virus season amid limited CDC data.

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms of a severe infection known as RSV or Respiratory Syncytial Virus. The ...

But with the overlap between the common cold, influenza (the flu), respiratory syncytial virus (RSV), and COVID-19, it can be ...

Compared with placebo, single-dose clesrovimab 105 mg reduced the risk for RSV-associated LRI and hospitalization in healthy infants.

Credit: Getty Images. RSV primarily affects children and older adults, and can lead to severe illness or death. Respiratory syncytial virus (RSV) affects infants, young children, and older adults, ...